Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?
Saved in:
| Main Authors: | Deepavalli Arumuganainar, Saravanan Sekaran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Oral Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024004217 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging celebrity influence for oral cancer prevention and smokeless tobacco cessation: challenges and opportunities in India
by: Saravanan Sekaran, et al.
Published: (2025-07-01) -
Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer
by: Saravanan Sekaran, et al.
Published: (2024-03-01) -
Rack1 and Pon1 as predictive hub genes in WNT-based oral cancer: an interactomic approach
by: Yadalam Pradeep Kumar, et al.
Published: (2025-01-01) -
Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies
by: Bharathi Selvaraj, et al.
Published: (2024-06-01) -
Repurposing riluzole as an anti-osteosarcoma agent
by: Okkeun Jung, et al.
Published: (2025-05-01)